Drägerwerk AG & Co. KGaA stock (DE0005550636): Xetra price levels and peer comparison mid-2026

Drägerwerk AG & Co. KGaA shares continue to trade steadily on the German Xetra market in May 2026, with the preference share recently quoted around 91.70 EUR intraday on 05/22/2026 according to comdirect data, underscoring the company’s role as a domestically listed medical and safety technology provider headquartered in Lübeck, Germany.

The stock’s home-country anchor remains clear: Drägerwerk’s primary listing is in Germany, where the group is a long-standing component of the local mid-cap universe and a familiar name to investors tracking German engineered healthcare and industrial safety equipment.

As of: 06/03/2026

By the editorial team - specialized in equity coverage.

Drägerwerk AG & Co. KGaA: core business model

Drägerwerk focuses on developing, manufacturing, and servicing medical and safety technology products that support hospitals, emergency services, and industrial customers, with revenue mainly generated from equipment sales complemented by consumables and service contracts.

Drägerwerk AG & Co. KGaA in peer comparison

From a peer perspective, Drägerwerk is often compared with listed medical technology and safety-equipment providers such as Siemens Healthineers in Germany and US-based players like Medtronic, which also derive a substantial share of sales from hospital-related devices and solutions, though with different product mixes and geographic footprints.

Siemens Healthineers, for example, is a DAX-listed company that emphasizes imaging and diagnostics and reported multi-billion-euro revenues in its most recent fiscal year, while Medtronic, listed on the New York Stock Exchange, disclosed multi-billion-dollar annual revenue with a broad portfolio across cardiovascular, neurology, and surgical technologies, placing Drägerwerk in a smaller but specialized niche focused more tightly on life-support systems, anesthesia, and gas detection.

Conclusion

The mid-2026 Xetra price level around the low 90-euro range places Drägerwerk AG & Co. KGaA firmly within the German medtech and safety-technology universe, where investors watch local trading data as part of their broader view on the sector.

Against larger global peers in Europe and the United States, the company represents a more specialized play on life-support and gas-detection systems, which typically leads market participants to focus on its niche strengths and regional exposure when assessing the stock’s role in diversified portfolios.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.